Involuntary job changes are frequent among breast cancer patients
Breast cancer diagnosis: Around 88 percent of patients survive the dangerous disease in the first five years. Work is important for getting back to normality. Researchers from the University of Bonn and the German Cancer Society investigated how satisfied former patients are with their occupational development over a period of five to six years since diagnosis. About half experienced at least one job change during the study period. Around ten percent of those affected even report involuntary changes. The researchers conclude that there is a need for long-term support measures for patients. The study is now published in the
E-Mail
Breast cancer diagnosis: Around 88 percent of patients survive the dangerous disease in the first five years. Work is important for getting back to normality. Researchers from the University of Bonn and the German Cancer Society investigated how satisfied former patients are with their occupational development over a period of five to six years since diagnosis. About half experienced at least one job change during the study period. Around ten percent of those affected even report involuntary changes. The researchers conclude that there is a need for long-term support measures for patients. The study is now published in the
Journal of Cancer Survivorship.
April 19, 2021
Observational data from Switzerland add support to the idea that age shouldn’t be a barrier to TAVI, researchers say. While nonagenarian patients in the SwissTAVI Registry had a higher mortality risk compared with younger TAVI patients, these individuals were no more likely to die than people of similar age in the general population.
The question of how well the very elderly fare after TAVI is of increasing importance as the global population ages. By 2050, there will be around 76.7 million people older than 90 years, many of whom will develop aortic stenosis and face the choice of whether to undergo an invasive procedure.
Expansion study planned upon definition of recommended dose to gather additional data Regulatory News: NOXXON Pharma N.V. (Euronext Growth Paris: ALNOX) (Paris:ALNOX), a biotechnology company
¿Existe una relación entre las vacunas vectoriales y la trombosis? | Coronavirus | DW dw.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dw.com Daily Mail and Mail on Sunday newspapers.